| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/12/2007 | EP1467712B1 Bilayer pharmaceutical tablet comprising telmisartan and hydrochlorothiazide |
| 12/12/2007 | EP1416942B1 Amine polymers for treating gout and binding uric acid |
| 12/12/2007 | EP1355668B1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 12/12/2007 | EP1331927B1 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
| 12/12/2007 | EP1295601A4 Pharmaceutical composition based on a non-steroid anti-inflammatory agent |
| 12/12/2007 | EP1143943B1 USE OF p53 INHIBITORS FOR THE TREATMENT OF SIDE EFFECTS OF CANCER THERAPY |
| 12/12/2007 | EP0894130B1 Modulators of tnf receptor associated factor (traf), their preparation and use |
| 12/12/2007 | EP0888377B1 MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII) |
| 12/12/2007 | EP0769967B1 Conjugates comprising an antitumour agent and their use |
| 12/12/2007 | CN101087782A (2-carboxamido)(3-amino) thiophene compounds |
| 12/12/2007 | CN101087602A Use of L-carnitine and flucose for the treatment of cardiovascular diseases |
| 12/12/2007 | CN101087593A Colonic purgative composition with soluble binding agent |
| 12/12/2007 | CN101085354A Anticancer composition containing semustine |
| 12/12/2007 | CN101085353A Anticancer composition containing nimustine |
| 12/12/2007 | CN101085352A Anticancer composition containing spiromustine |
| 12/12/2007 | CN101085351A Anticancer composition containing uramustine |
| 12/12/2007 | CN101085350A Anticancer composition containing samostine |
| 12/12/2007 | CN101085349A Vesicle guiding immunocyte and application of the same in preparing antineoplastic medicine |
| 12/12/2007 | CN101084886A 联合化学疗法 Combined chemotherapy |
| 12/12/2007 | CN101084877A Anti-cancer composition containing fotemustine |
| 12/12/2007 | CN101084876A Anti-cancer composition containing bendamustine |
| 12/12/2007 | CN101084875A Anti-cancer composition containing estramustine |
| 12/12/2007 | CN100354002C New type of cell vaccine with heteroimmune cell as cell vector and its prepn process |
| 12/12/2007 | CN100354001C Melanocyte suspension and its preparation for treating leukodermia |
| 12/12/2007 | CN100353999C Pharmaceutical compositions of fibrinolytic agent |
| 12/12/2007 | CN100353946C Method of treating functional bowel disorders |
| 12/12/2007 | CN100353935C Pharmaceutical formulation contg. tolterodine and its use |
| 12/12/2007 | CN100353934C Compound control-released percutaneous medicine plaster for treating high blood pressure and its preparation method |
| 12/12/2007 | CN100353866C Stimulation of in vivo production of proteins with formulation comprising leucine |
| 12/11/2007 | US7307154 DNA encoding a novel RG1 polypeptide |
| 12/11/2007 | US7307102 Administering selective estrogen receptor modulators that possesses tissue-specific ER agonist activity |
| 12/11/2007 | US7307101 Administering N-hydroxy-N-(4-butyl-2-methylphenyl)-formamidine (HET0016) to increase or prevent a decrease in cerebral blood flow |
| 12/11/2007 | US7307096 For intraocular pressure lowering action; for therapy and prophylaxis |
| 12/11/2007 | US7307087 Antidepressants; analgesics; antiinflammatory agents; side effect reduction |
| 12/11/2007 | US7307071 RAF-MEK-ERK pathway inhibitors to treat cancer |
| 12/11/2007 | US7306922 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof |
| 12/11/2007 | US7306920 Gene associated with regulation of energy balance, obesity and diabetes and uses therefor |
| 12/11/2007 | US7306903 Use of test cells comprising DNA defining a morphogen-responsive transcription activating element operatively associated with reporter gene, increase in expression of detectable gene product after exposing test cell to candidate compound indicates ability of compound to induce morphogen-mediated effect |
| 12/11/2007 | US7306902 Detecting ras-activated neoplastic cells by contacting sample with a reovirus and determining its ability to replicate; use in diagnosis and treatment of interferon-sensitive, p53/Rb deficient tumors |
| 12/11/2007 | US7306804 HIV-specific T-cell induction |
| 12/11/2007 | US7306797 Use of a compound antagonist of ESM-1 protein for producing a medicine for treating cancer |
| 12/11/2007 | US7306791 Comprising Tumor cytotoxic factor-II or Hepatocyte growth factor as an effective ingredient |
| 12/11/2007 | US7306787 Engineered particles and methods of use |
| 12/11/2007 | CA2420766C Trace elements |
| 12/11/2007 | CA2370202C Gum pad for delivery of medication to mucosal tissues |
| 12/11/2007 | CA2348735C Heterocyclic potassium channel inhibitors |
| 12/11/2007 | CA2348245C Treatment of rumen acidosis with .alpha.-amylase inhibitors |
| 12/11/2007 | CA2259141C Treatment and diagnosis of infections of gram positive cocci |
| 12/11/2007 | CA2224164C Intrauterine chemical necrosing method and composition |
| 12/06/2007 | WO2007139887A2 Methods for treating bone or joint inflammation |
| 12/06/2007 | WO2007139232A1 Insulin sensitivity enhancer |
| 12/06/2007 | WO2007139208A1 Pharmaceutical composition for prevention or treatment of disease associated with platelet adhesion/aggregation reaction, and method for screening for the same |
| 12/06/2007 | WO2007139153A1 Function-improving agent for cerebral dysfunction caused by environmental chemical |
| 12/06/2007 | WO2007139150A1 ANTI-INFLUENZA VIRAL AGENT COMPRISING TNF-α INHIBITOR |
| 12/06/2007 | WO2007139062A1 Therapeutic agent for obesity, and method for treatment and prevention of obesity |
| 12/06/2007 | WO2007138086A1 Long term 24 hour intestinal administration of levodopa/carbidopa |
| 12/06/2007 | WO2007109142A3 M3 muscarinic receptor antagonists for treating tumors |
| 12/06/2007 | WO2005062878A3 Canine probiotic bifidobacteria globosum |
| 12/06/2007 | WO2004060304A3 Novel compositions and methods in cancer |
| 12/06/2007 | US20070282009 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 12/06/2007 | US20070282004 Use of a Cyclopentenone Prostaglandin for Delaying for the Onset and/or Preventing the Continuation of Labour |
| 12/06/2007 | US20070281986 Methods and Compositions for Modulating Satiety |
| 12/06/2007 | US20070281984 Use Of Metronidazole For Preparing A Pharmaceutical Composition For Treating A Cutaneous Inflammation |
| 12/06/2007 | US20070281968 Compounds Derived From Artesunate, Preparation Process, Pharmaceutical Composition And Use Of The Respective Medicine |
| 12/06/2007 | US20070281967 Nuclear Transfer Promoter For Rac Protein And Method Of Screening The Dame |
| 12/06/2007 | US20070281931 Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate |
| 12/06/2007 | US20070281912 treating with a mixture comprising nomegestrol acetate and estradiol valerate or estradiol; side effect reduction |
| 12/06/2007 | US20070281911 Use of Adefovir or Tenofovir for Inhibiting Mmtv-Like Viruses Involved in Breast Cancer and Primary Biliary Cirrhosis |
| 12/06/2007 | US20070281328 identifying a test agent as reducing apoptosis of a macrophage cell; reducing the activity of Protein Kinase R |
| 12/06/2007 | US20070281042 Combinations of chromium with antidiabetics for glucose metabolism disorders |
| 12/06/2007 | US20070281041 Compositions and Methods Involving MDA-7 for the Treatment of Cancer |
| 12/06/2007 | US20070281028 Drug Delivery of a Cox Inhibitor from Embolic Agents |
| 12/06/2007 | US20070280980 Percutaneous Pharmaceutical Preparation for External Use Containing Nonsteroidal Antiinflammatory Analgesic |
| 12/06/2007 | US20070280970 Methods of Treating Wounds With Gonyautoxins |
| 12/06/2007 | US20070280950 Inflammatory Cytokine Inhibitors |
| 12/06/2007 | US20070280944 Use of 5,10-Methylene Tetrahydrofolate for the Treatment of Cancer |
| 12/06/2007 | US20070280915 Combination Therapies Employing A Composition Comprising A Hmg Coa Reductase Inhibitor And A Vitamin B6 Related Compound |
| 12/06/2007 | US20070277393 Cabinet for automatic washing or/and drying machine and automatic washing or/and drying machine with the same |
| 12/06/2007 | DE102006026464A1 Pharmazeutische Zusammensetzung zur Behandlung von Virusinfektionen und / oder Tumorerkrankungen durch Inhibition der Proteinfaltung und des Proteinabbaus A pharmaceutical composition for the treatment of viral infections and / or tumors by inhibition of protein folding and protein degradation |
| 12/05/2007 | EP1862544A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 12/05/2007 | EP1862470A1 Element retained in blood showing degradability selectively in tumor tissue |
| 12/05/2007 | EP1862182A2 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
| 12/05/2007 | EP1862181A2 Combination therapy using an 11B-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders |
| 12/05/2007 | EP1862180A1 Prophylactic/therapeutic agent for cancer |
| 12/05/2007 | EP1862179A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
| 12/05/2007 | EP1862167A2 Methods and formulations for the treatment of female sexual dysfunction |
| 12/05/2007 | EP1862165A2 Prevention and treatment of androgen-deprivation induced hot flashes |
| 12/05/2007 | EP1861111A2 Methods and compositions for increasing the safety and efficacy of albumin-binding drugs |
| 12/05/2007 | EP1861110A1 Antibiotic combinations for providing total solution to the treatment of infections |
| 12/05/2007 | EP1861096A2 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 12/05/2007 | EP1861094A2 Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors |
| 12/05/2007 | EP1861091A1 Compounds having lipid lowering properties |
| 12/05/2007 | EP1861085A1 Antiviral compositions and methods of use |
| 12/05/2007 | EP1433479B1 Appetite-stimulating agents and remedies for anorexia |
| 12/05/2007 | EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof |
| 12/05/2007 | EP1368318B1 Calcilytic compounds |
| 12/05/2007 | EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 12/05/2007 | EP1148872B1 Stable pharmaceutical formulation comprising pravastatin or atorvastatin |
| 12/05/2007 | EP1141358B1 STABLY TRANSFECTED CELLS FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF mRNA |
| 12/05/2007 | EP1073418B1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin |